MD1137G2 - Metodă de tratament al sterilităţii feminine - Google Patents

Metodă de tratament al sterilităţii feminine

Info

Publication number
MD1137G2
MD1137G2 MD98-0135A MD980135A MD1137G2 MD 1137 G2 MD1137 G2 MD 1137G2 MD 980135 A MD980135 A MD 980135A MD 1137 G2 MD1137 G2 MD 1137G2
Authority
MD
Moldova
Prior art keywords
woman
treatment
mononuclear cells
srerility
administration
Prior art date
Application number
MD98-0135A
Other languages
English (en)
Russian (ru)
Other versions
MD1137F1 (ro
Inventor
Георге КУШНИР
Валентин ФРИПТУ
Исаак Гершевич ШРОЙТ
Angela Pavlenco
Original Assignee
Георге КУШНИР
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Георге КУШНИР filed Critical Георге КУШНИР
Priority to MD98-0135A priority Critical patent/MD1137G2/ro
Publication of MD1137F1 publication Critical patent/MD1137F1/ro
Publication of MD1137G2 publication Critical patent/MD1137G2/ro

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Invenţia se referă la medicină, în special la ginecologie şi poate fi utilizată în cadrul tratamentului sterilităţii feminine cauzate de afecţiuni inflamatorii ale organelor genitale.Esenţa invenţiei constă în aceea că se administrează paracervical suspensie de cultură de celule mononucleare obţinute din sângele recipientei şi intrauterin supernatantul obţinut la izolarea culturii de celule mononucleare din suspensie.Rezultatul tehnic constă în intensificarea reacţiilor imune, inhibiţia reacţiei inflamatoare şi resorbţia aderenţelor.
MD98-0135A 1998-06-22 1998-06-22 Metodă de tratament al sterilităţii feminine MD1137G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD98-0135A MD1137G2 (ro) 1998-06-22 1998-06-22 Metodă de tratament al sterilităţii feminine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD98-0135A MD1137G2 (ro) 1998-06-22 1998-06-22 Metodă de tratament al sterilităţii feminine

Publications (2)

Publication Number Publication Date
MD1137F1 MD1137F1 (ro) 1999-01-31
MD1137G2 true MD1137G2 (ro) 1999-07-31

Family

ID=19739179

Family Applications (1)

Application Number Title Priority Date Filing Date
MD98-0135A MD1137G2 (ro) 1998-06-22 1998-06-22 Metodă de tratament al sterilităţii feminine

Country Status (1)

Country Link
MD (1) MD1137G2 (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2396G2 (ro) * 2003-11-13 2004-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de tratament al ulcerelor duodenale cronice şi recidivante postoperatorii

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Cuplul steril. Indicaţii metodice. Chişinău, Universitas, 1991, p. 28-30 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2396G2 (ro) * 2003-11-13 2004-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de tratament al ulcerelor duodenale cronice şi recidivante postoperatorii

Also Published As

Publication number Publication date
MD1137F1 (ro) 1999-01-31

Similar Documents

Publication Publication Date Title
ATE153856T1 (de) Zusammensetzung zur stimulierung des immunsystems
TW376320B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
UA81390C2 (en) Use of unrestricted somatic stem cells (ussc) for the preparation of medicinal agents
NZ514077A (en) Treatment of Α-galactosidase A deficiency
BG66114B1 (bg) Многофазов състав на дросперидон като контрацептив
AU3844297A (en) Treatment of autoimmune diseases
DE69905368D1 (en) Oxydiertes thymosin beta 4
SI1644009T1 (en) COMPOSITION TO INCREASE TELECOMMUNICATION ACTIVITY AND TREATMENT OF HIV INFECTION
JPS60231803A (ja) 女性パンツの嵌入防止装置
Mikkelsen et al. (6; 15) Translocation with loss of chromosome material in the patient and various chromosome aberrations in family members
BR0014380A (pt) Usos de modafinil e seus enanciÈmeros d/l
MX9702926A (es) L-eritrosilnucleosidos.
AU2623700A (en) Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
MD1119G2 (ro) Metodă de tratament al afecţiunilor inflamatorii ale organelor genitale feminine
MD1137G2 (ro) Metodă de tratament al sterilităţii feminine
EP1352955A3 (en) HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constitutuent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
MX9803610A (es) Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico.
Bayless et al. Budesonide enema is an effective alternative to hydrocortisone enema in active distal ulcerative colitis
GR3018632T3 (en) Beta-alethine use in cell culture and therapy.
MX9702927A (es) L-piranosilnucleosidos.
MD1475F1 (ro) Metoda de profilaxie a endometritei puerperale
MD2355F1 (ro) Metoda de pregatire preimplantare
MD1135F1 (ro) Metoda de tratament al afectiunilor parodontiului
MD1474F1 (ro) Metoda de tratament al endometritei puerperale
GB9617611D0 (en) Treatment of autoimmune disease